Cargando…
Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model
Cannabidiol is a promising potential therapeutic for neurodegenerative diseases, including Alzheimer’s disease (AD). Our laboratory has shown that oral CBD treatment prevents cognitive impairment in a male genetic mouse model of AD, the amyloid precursor protein 1 x presenilin 1 hemizygous (APPxPS1)...
Autores principales: | Chesworth, Rose, Cheng, David, Staub, Chloe, Karl, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551202/ https://www.ncbi.nlm.nih.gov/pubmed/36238565 http://dx.doi.org/10.3389/fphar.2022.931384 |
Ejemplares similares
-
T177. CANNABIDIOL AS A POTENTIAL PREVENTATIVE TREATMENT IN A NEUREGULIN-1 MOUSE MODEL OF SCHIZOPHRENIA
por: Visini, Gabriela, et al.
Publicado: (2020) -
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
por: Watt, Georgia, et al.
Publicado: (2017) -
The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
por: Visini, Gabriela, et al.
Publicado: (2022) -
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
por: Jurkus, Regimantas, et al.
Publicado: (2016) -
Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP
(Swe)
/PS1ΔE9 Transgenic Female Mice
por: Coles, Madilyn, et al.
Publicado: (2020)